Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bode

Showing results (261-270 of 589) with videos related to

Pageof 59
Sort By:
European Journal of Biochemistry|March 1, 1985
The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3)W Bode, O Epp, R Huber, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2015
Chemical Synthesis of the 20 kDa Heme Protein Nitrophorin 4 by α-Ketoacid-Hydroxylamine (KAHA) LigationChunmao He, Sameer S Kulkarni, Frédéric Thuaud, et al.
Organic Letters|June 26, 2018
Synthesis of N, N-Alkylated α-Tertiary Amines by Coupling of α-Aminoalkyltrifluoroborates and Grignard ReagentsMoritz K Jackl, Anne Schuhmacher, Tomoya Shiro, et al.
Angewandte Chemie (International Ed. in English)|July 4, 2001
A General Solution to the Modular Synthesis of Polyketide Building Blocks by Kanemasa Hydroxy-Directed Nitrile Oxide Cycloadditions This work was supported by the ETH-Zürich, Hoffmann-LaRoche, Merck, and Novartis. J.W.B. thanks the National Science Foundation (USA) for a predoctoral fellowship. We are grateful to Boehringer-Ingelheim for a generous gift of (R)-3-buten-2-olJeffrey W. Bode, Nina Fraefel, Dieter Muri, et al.
Journal of Molecular Biology|February 5, 1990
Refined three-dimensional structure of phycoerythrocyanin from the cyanobacterium Mastigocladus laminosus at 2.7 AM Duerring, R Huber, W Bode, et al.
The American Journal of Geriatric Pharmacotherapy|November 8, 2011
Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studiesBruce W Bode, Jason Brett, Ali Falahati, et al.
Journal of Enzyme Inhibition|January 1, 1995
The X-ray crystal structure of thrombin in complex with N alpha-2-naphthylsulfonyl-L-3-amidino-phenylalanyl-4-methylpiperidide: the beneficial effect of filling out an empty cavityA Bergner, M Bauer, H Brandstetter, et al.
Trends in Biotechnology|December 1, 1995
Divining the serpin inhibition mechanism: a suicide substrate 'springe'?R A Engh, R Huber, W Bode, et al.
Journal of Molecular Biology|August 20, 1992
Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolutionU Baumann, W Bode, R Huber, et al.
Biological Chemistry Hoppe-Seyler|July 1, 1992
Interactions of thrombin with benzamidine-based inhibitorsJ Stürzebecher, H Vieweg, P Wikström, et al.
Pageof 59

Showing results (261-270 of 589) with videos related to

Sort By:
Pageof 59
European Journal of Biochemistry|March 1, 1985
The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3)W Bode, O Epp, R Huber, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2015
Chemical Synthesis of the 20 kDa Heme Protein Nitrophorin 4 by α-Ketoacid-Hydroxylamine (KAHA) LigationChunmao He, Sameer S Kulkarni, Frédéric Thuaud, et al.
Organic Letters|June 26, 2018
Synthesis of N, N-Alkylated α-Tertiary Amines by Coupling of α-Aminoalkyltrifluoroborates and Grignard ReagentsMoritz K Jackl, Anne Schuhmacher, Tomoya Shiro, et al.
Angewandte Chemie (International Ed. in English)|July 4, 2001
A General Solution to the Modular Synthesis of Polyketide Building Blocks by Kanemasa Hydroxy-Directed Nitrile Oxide Cycloadditions This work was supported by the ETH-Zürich, Hoffmann-LaRoche, Merck, and Novartis. J.W.B. thanks the National Science Foundation (USA) for a predoctoral fellowship. We are grateful to Boehringer-Ingelheim for a generous gift of (R)-3-buten-2-olJeffrey W. Bode, Nina Fraefel, Dieter Muri, et al.
Journal of Molecular Biology|February 5, 1990
Refined three-dimensional structure of phycoerythrocyanin from the cyanobacterium Mastigocladus laminosus at 2.7 AM Duerring, R Huber, W Bode, et al.
The American Journal of Geriatric Pharmacotherapy|November 8, 2011
Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studiesBruce W Bode, Jason Brett, Ali Falahati, et al.
Journal of Enzyme Inhibition|January 1, 1995
The X-ray crystal structure of thrombin in complex with N alpha-2-naphthylsulfonyl-L-3-amidino-phenylalanyl-4-methylpiperidide: the beneficial effect of filling out an empty cavityA Bergner, M Bauer, H Brandstetter, et al.
Trends in Biotechnology|December 1, 1995
Divining the serpin inhibition mechanism: a suicide substrate 'springe'?R A Engh, R Huber, W Bode, et al.
Journal of Molecular Biology|August 20, 1992
Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolutionU Baumann, W Bode, R Huber, et al.
Biological Chemistry Hoppe-Seyler|July 1, 1992
Interactions of thrombin with benzamidine-based inhibitorsJ Stürzebecher, H Vieweg, P Wikström, et al.
Pageof 59